Rui Sato Selected Research

Therapeutics

1/2023	Secondary Budd-Chiari syndrome occurred after adjuvant radiotherapy for perihilar cholangiocarcinoma: a case report.
10/2022	Real-world outcomes of molecular targeted agents for patients with hepatocellular carcinoma over 80 years old.
1/2022	Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rui Sato Research Topics

Disease

6	Neoplasms (Cancer) 03/2023 - 10/2013
4	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 08/2017
3	Thrombosis (Thrombus) 01/2023 - 11/2017
3	Insulin Resistance 11/2015 - 09/2013
2	Disease Progression 01/2023 - 01/2022
2	Shock 06/2013 - 01/2007
1	Adenocarcinoma 10/2023
1	Hematuria 10/2023
1	Lymphadenopathy 03/2023
1	Neoplasm Metastasis (Metastasis) 03/2023
1	Breast Neoplasms (Breast Cancer) 03/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Klatskin Tumor 01/2023
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2023
1	Pulmonary Embolism 10/2022
1	Fibrosis (Cirrhosis) 09/2020
1	Cytopenia 11/2017
1	Abscess 08/2017
1	Hyperinsulinism (Hyperinsulinemia) 06/2014
1	Hemorrhagic Shock 06/2013
1	Acidosis 06/2013
1	Acid-Base Imbalance 06/2013
1	Hyperlactatemia 06/2013
1	Wounds and Injuries (Trauma) 02/2010
1	Septic Shock (Toxic Shock Syndrome) 01/2007
1	Drug Overdose 01/2007

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 11/2015 - 09/2013
3	Sevoflurane (Ultane)FDA LinkGeneric 06/2014 - 06/2013
3	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 06/2013
2	Propofol (Diprivan)FDA LinkGeneric 06/2014 - 09/2013
1	GelatinIBA 10/2023
1	BismuthIBA 01/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2020
1	Plasminogen Activator Inhibitor 1IBA 09/2020
1	Fluorouracil (Carac)FDA LinkGeneric 11/2017
1	Sorafenib (BAY 43-9006)FDA Link 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2017
1	LipidsIBA 06/2014
1	CytokininsIBA 10/2013
1	Indoleacetic Acids (Auxin)IBA 10/2013
1	alpha-naphthylphthalamic acidIBA 10/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2013
1	1-naphthoxyacetic acidIBA 10/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013
1	AdiponectinIBA 09/2013
1	dextran - saline drug combination (L-410)IBA 06/2013
1	Dextrans (Dextran)FDA Link 06/2013
1	Bicarbonates (Hydrogen Carbonate)IBA 06/2013
1	CatecholaminesIBA 01/2007
1	Vasopressins (Vasopressin)IBA 01/2007

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 03/2023 - 11/2017
3	Therapeutics 01/2023 - 01/2022
3	Anesthesia 06/2014 - 06/2013
2	Radiotherapy 03/2023 - 01/2023
1	Aftercare (After-Treatment) 10/2023
1	Vascular Access Devices (Arterial Line) 03/2023
1	Pancreaticoduodenectomy 01/2023
1	Adjuvant Radiotherapy 01/2023
1	Stents 01/2023
1	Hepatectomy 01/2023
1	Palliative Care (Palliative Therapy) 06/2020
1	Radiofrequency Ablation 08/2017
1	Laparotomy 11/2015
1	Resuscitation 06/2013
1	Laryngoscopes 02/2010